云锡矿工肺癌的时间序列预测与分析

本文采用时间序列方法中的 AR 模型和非平稳时间序模型对云锡老矿各年代下井矿工的肺癌死亡进行了预测,得到了1936～1995年期间各组矿工肺癌死亡的预测情况,并在此基础上进行了分析,对解放后所采取的防护、防治措施的奏效程度进行了评价,对云锡矿工肺癌的发病趋势作了宏观和微观的结论,是一篇综合性的论文报告。     

微量元素锰与肺癌的关系

本文对锰含量的测定表明:肺癌患者发锰含量显著低于对照者(P<0.01)。在动物诱癌实验中观察到,随着肿瘤的发生和发展,肝、肺中锰含量降低,而肿瘤部位锰含量则升高,提示锰含量低可能是肺癌发病的结果。     

上消化道病内镜微波组织凝固疗法的临床应用与评价

本文报告应用内镜微波组织凝固疗法(EMCT)治疗胃息肉、胃癌、消化性溃疡三种疾病21例、39次治疗。提出了溃疡面搔刮加微波凝固治疗难治性溃疡、及EMCT联合内镜下局部注射化疗治疗进展期胃癌等方法。胃息肉13例27枚及Ⅱa型早期胃癌1例与消化性溃疡3例全部达到治愈。85.2％的胃息肉EMCT一次治疗成功,Ⅱa型早癌一次成功,消化性溃疡2例一次成功。进展期胃癌4例均达到肿块缩小、狭窄的胃腔扩大与自觉症状改善的效果。鉴于疗效显著,认为三种疾病均适用本疗法;并就EMCT的适应症、使用限度和治疗目的作了讨论;展望了以EMCT作为早期胃癌经内镜根治疗法手段之一的远景。     

Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding

Peptide aptamers have emerged as powerful new tools for molecular medicine. They can specifically bind to and functionally inactivate a given target molecule under intracellular conditions. Typically, peptide aptamers are generated by screening a randomized peptide expression library, displayed from the Escherichia coli thioredoxin A (TrxA) protein. Here, we transferred peptide moieties from defined TrxA-based peptide aptamers to alternative scaffold proteins, such as the green fluorescent protein and staphylococcal nuclease. Yeast and mammalian two-hybrid assays as well as in vitro binding analyses show that the TrxA scaffold can be a major determinant for the binding of peptide aptamers. In addition, we demonstrate that TrxA can correctly display peptide sequences that correspond to the binding domains of natural interaction partners. Therefore, sequence analyses of TrxA-based peptide aptamers, isolated by two-hybrid screening from randomized expression libraries, should also be useful to find cellular binding partners for a given target protein, by homology. Received 1 August 2002; received after revision 17 September 2002; accepted 19 September 2002 RID="*" ID="*"Corresponding author.     

PCNA,KI67在胃黏膜良恶性病变中表达的临床研究

目的　探讨增殖细胞抗原PCNA,KI67在胃黏膜良恶性病变中表达的临床意义.方法　采用免疫组织化学方法,对44例胃溃疡恶变的胃癌切除术标本中胃癌组织、周围黏膜及正常黏膜中PCNA,Ki67的表达进行检测,分析细胞的增殖状态及恶性程度.结果　PCNA,Ki67在胃癌组织及癌周组织中均呈现高表达状态,而正常黏膜则呈现低表达,两者均具有显著性差异(P<0.05).结论　PCNA及ki67的表达情况可为高危人群胃黏膜病变的重要诊断指标.     

Progress in non-viral gene delivery systems fabricated via supramolecular assembly

Gene delivery systems are one of key issues that limit the development of gene therapy. The novel non-viral gene delivery systems fabricated via supramolecular assembly have begun to show increasing promising and applications in gene therapy due to its suitable nanometric size,controllable structure and excellent biocompatibility. In this review, the fundamental and recent progress of non-viral gene supramolecular assembly is reviewed. Artificial viruses the future direction of non-viral gene delivery systems are also described.     

卵巢癌中的表观遗传修饰

介绍了在卵巢癌的发展和治疗中表观遗传学的重要性，特别强调了在卵巢癌中内源性和获得性耐药性遗传途径中异常的DNA甲基化和组蛋白去乙酰化的重要性．通过表观遗传治疗反转肿瘤抑制基因沉寂和其他参与药物级联反应的基因沉寂为出现耐药性的卵巢癌患者带来了新的希望．     

Investigation of hrDNA targeting vector-mediated tumor-specific suicide gene therapy for hepatocellular carcinoma

Vectors pose most pivotal problem of gene therapy[1]. Because of the high transfection efficiency both in vitro and in vivo, the viral vector has been employed in 70% clinical trials of gene therapy (http://www.wiley.co.uk/ genmed/clinical). However, thei…     

血管生成抑制剂与肺癌治疗的研究进展

目的:探讨血管生成抑制剂治疗肺癌的研究进展.方法:收集该类药物的国内外近期资料加以综合归纳.结果:血管生成抑制剂治疗肺癌方法可行,前景诱人.结论:随着血管生成抑制剂的不断开发和研究,对于肺癌这一血管增生明显的肿瘤,深入研究抗血管治疗具有重要意义.     

BNCT物理剂量Monte Carlo程序系统——MCDB及算法

硼中子俘获治疗(BNCT,boron neutron capture therapy)规划软件系统MCDB(Monte Carlo dosimetry inbrain),包括医学前处理、Monte Carlo物理剂量计算和后处理。采用中心点方法确定网格的材料和密度,并自动生成Monte Carlo输入文件。MCDB借鉴并发展了一套网格几何下的快速粒子径迹算法,取得了与MCNP程序一致的剂量计算结果,计算速度较MCNP程序提高2.7~3.5倍。MCDB可进行并行计算,具有线性加速比,能够满足BNCT临床对计算时间和精度的要求。